Bioconjugate Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugate field, including ADCs, oligonucleotide conjugates, protein and peptide conjugates, PEGylation, radioconjugates, conjugated vaccines, diagnostics, and more.
Bioconjugate Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation.
We address critical challenges and highlight the latest developments in bioconjugates, publishing original research articles, expert reviews, commentary, case studies, and more. Visit the Bioconjugate Insights Journal page for our comprehensive collection.
Our informative webinar series offers expert-led discussions on significant breakthroughs, novel methodologies, and strategic insights, aimed at supporting continued professional growth and innovation in bioconjugation.
Explore our content for targeted insights into key areas, including conjugation chemistry, analytics, manufacturing processes, and regulatory considerations essential to effective bioconjugate development.
Learn more about our journal’s mission, scope, and publication guidelines by visiting our detailed aims and scope.
Sign-up for free to access our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the forefront of bioconjugation innovation.
If you’re interested in collaborating through sponsorship opportunities, webinars, articles, or other initiatives, please view our media kit to learn more.
| Expert-led content on translation and commercialization in life sciences BioInsights brings together peer-reviewed insights, expert analysis, and industry perspectives from across the biopharma landscape, spanning the cell and gene therapy, nucleic acids, vaccines, and bioconjugates fields, from early discovery through to clinical development and commercialization. Contact us to see how we can partner with you. Contact us |  |
| Translation-driven insights across the cell and gene therapy lifecycle Cell & Gene Therapy Insights is an online, open-access, peer-reviewed journal dedicated to the interdisciplinary exploration and advancement of cell and gene therapy. Through translational focus, we bridge academia and industry to support preclinical and clinical development, scale-up, and commercialization. Register below to access all of our content for free. Contact us |  |
Vaccine Insights is an online, open-access, peer-reviewed journal focused on advances and innovation within vaccine R&D and manufacturing.
Guided by an expert advisory board, the journal brings together leading experts from pharma, biotech, academia, and other key stakeholders to address critical issues and put the latest developments into context.
We address key challenges and explore the latest advances in vaccine development, production, and supply, publishing reviews, commentary, original research articles, and more.. Visit the Vaccine Insights Journal page to access our full collection.
Our informative webinar series provides expert-led discussions covering major developments, emerging technologies, and strategic considerations, designed to foster continued professional growth and collaboration in vaccine science.
Explore our specialised channels for targeted insights into critical areas, including dedicated immune response and clinical update channels essential for effective vaccine development and deployment.
Learn more about our journal’s aims, scope, and publishing guidelines by visiting our detailed aims and scope.
Sign-up for free to gain unlimited access to our extensive collection of articles, webinars, podcasts, news, and interviews, and remain at the forefront of vaccine innovation.
If you’re interested in partnering with us through sponsored content, webinars, articles, or other collaborations, please view our media kit to find out more.
Closed Publications
Immuno-Oncology Insights has ceased publication. However, all published content remains available here. |
Immuno-Oncology Insights was an open access, independently peer reviewed publication specifically designed to fill a number of clear and important gaps in the slate of journals for the industrial and academic and immuno-oncology communities.
Guided by an editorial board lead by Jon Wigginton and Renier J Brentjens, Immuno-Oncology Insights placed R&D and manufacturing challenges and progress across a wide variety of technology fields in context.
To find out more or to access some of our fantastic content, visit Immuno-Oncology Insights.